News & Updates

The mortality rate following an incidence of out-of-hospital cardiac arrest (OHCA) is highest in the first 3 years post-event, gradually reducing over time, according to a study from Singapore.

Elevated uric acid concentration appears to contribute to an increased risk of atrial fibrillation (AF) regardless of the presence of cardiovascular disease and cardiovascular risk factors, according to a study.

Delivery of continuous, in situ–targeted, ultrahigh concentration of antibiotics (CITA) is a safe and effective therapy for patients with pocket infection who are neither suited nor willing to undergo extraction of implanted cardiovascular electronic device, reports a study.

Direct oral anticoagulants (DOACs) are as effective and safe as vitamin K antagonists (VKAs) among octogenarians with venous thromboembolism (VTE), a study has shown.

Vigorous intensity exercise helps slow the progression of coronary atherosclerosis, whereas very vigorous intensity exercise seems to be associated with greater progression, according to a study that involved male athletes.

The goals of diabetes care are to prevent complications and optimize quality of life. Current developments in diabetes management have shifted focus from just glycemic control to the inclusion of organ protection. In the Boehringer Ingelheim-sponsored webinar entitled “Deep dive in EMPA-KIDNEY” held last December 9, 2022, Dr Nestor Eric Laplano, Consultant, Skyline Hospital and Medical Center and Grace General Hospital, SJDM Bulacan; and Dr David Cherney, Active Consultant, University Health Network and Mount Sinai Hospital Toronto Canada, revisited treatment strategies and discussed the EMPA-KIDNEY trial and its implications in organ protective therapies for type 2 diabetes.

[ Dr David Cherney ]
Dr David Cherney
Speaker

[ Dr Nestor Eric Laplano ]
Dr Nestor Eric Laplano
Moderator